Juan Carlos Ruiz Ruiz-rekin lankidetzan egindako argitalpenak (31)

2016

  1. Phase I open label liver-directed gene therapy clinical trial for acute intermittent porphyria

    Journal of Hepatology, Vol. 65, Núm. 4, pp. 776-783

2011

  1. Treatment of chronic viral hepatitis in woodchucks by prolonged intrahepatic expression of Interleukin-12

    Journal of Virology

2010

  1. A phase i clinical trial of thymidine kinase-based gene therapy in advanced hepatocellular carcinoma

    Cancer Gene Therapy, Vol. 17, Núm. 12, pp. 837-843

  2. Effects of IFN-α as a signal-3 cytokine on human naïve and antigen-experienced CD8+ T cells

    European Journal of Immunology, Vol. 40, Núm. 12, pp. 3389-3402

2009

  1. Production of recombinant woodchuck IFNα and development of monoclonal antibodies

    Journal of Interferon and Cytokine Research, Vol. 29, Núm. 2, pp. 75-81

  2. Treatment of chronic viral hepatitis in woodchucks by prolonged intrahepatic expression of interleukin-12

    Journal of Virology, Vol. 83, Núm. 6, pp. 2663-2674

2007

  1. Woodchuck dendritic cells generated from peripheral blood mononuclear cells and transduced with recombinant human adenovirus serotype 5 induce antigen-specific cellular immune responses

    Journal of Medical Virology, Vol. 79, Núm. 5, pp. 522-529

2005

  1. Dendritic cells delivered inside human carcinomas are sequestered by interleukin-8

    International Journal of Cancer, Vol. 116, Núm. 2, pp. 275-281

  2. Enhancement of CD4 and CD8 immunity by anti-CD137 (4-1BB) monoclonal antibodies during hepatitis C vaccination with recombinant adenovirus

    Vaccine, Vol. 23, Núm. 27, pp. 3493-3499

  3. IFN-α gene therapy for woodchuck hepatitis with adeno-associated virus: Differences in duration of gene expression and antiviral activity using intraportal or intramuscular routes

    Molecular Therapy, Vol. 12, Núm. 1, pp. 68-76

  4. Induction of gp120-specific protective immune responses by genetic vaccination with linear polyethylenimine-plasmid complex

    Vaccine, Vol. 23, Núm. 11, pp. 1384-1392

  5. Intratumoral injection of dendritic cells engineered to secrete interleukin-12 by recombinant adenovirus in patients with metastatic gastrointestinal carcinomas

    Journal of Clinical Oncology, Vol. 23, Núm. 5, pp. 999-1010

  6. Modulation of vaccine-induced immune responses to hepatitis C virus in rhesus macaques by altering priming before adenovirus boosting

    Journal of Infectious Diseases, Vol. 192, Núm. 5, pp. 920-929

  7. Positron emission tomography imaging of adenoviral-mediated transgene expression in liver cancer patients

    Gastroenterology, Vol. 128, Núm. 7, pp. 1787-1795

  8. Topical application of a peptide inhibitor of transforming growth factor-β1 ameliorates bleomycin-induced skin fibrosis

    Journal of Investigative Dermatology, Vol. 125, Núm. 3, pp. 450-455

2004

  1. Phase I trial of intratumoral injection of an adenovirus encoding interleukin-12 for advanced digestive tumors

    Journal of Clinical Oncology, Vol. 22, Núm. 8, pp. 1389-1397

2002

  1. Gene therapy for liver diseases: Recent strategies for treatment of viral hepatitis and liver malignancies

    Gut, Vol. 50, Núm. 1, pp. 130-135

  2. The woodchuck interferon-α system: Cloning, family description, and biologic activity

    Journal of Medical Virology, Vol. 68, Núm. 3, pp. 424-432

  3. Tracing transgene expression in cancer gene therapy: A requirement for rational progress in the field

    Molecular Imaging and Biology, Vol. 4, Núm. 1, pp. 27-33

  4. Vaccination with an adenoviral vector encoding hepatitis C virus (HCV) NS3 protein protects against infection with HCV-recombinant vaccinia virus

    Vaccine, Vol. 21, Núm. 3-4, pp. 202-210